戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  therapy with corticosteroids and polyclonal antilymphocyte globulin.
2  patients who received alemtuzumab or rabbit antilymphocyte globulin.
3 on; CsA pigs (n= 14) received CsA (5 mg/kg), antilymphocyte globulin (10 mg/kg for 10 days), predniso
4 ding to the use of induction therapy: rabbit antilymphocyte globulin (5-year rate 6.8%, 4/59), alemtu
5            In the current study, addition of antilymphocyte globulin (ALG) to the TBI/CyP-based condi
6            LIS1, the first new generation of antilymphocyte globulins (ALGs) derived from double knoc
7     The relative risk was 0.82 for Minnesota antilymphocyte globulin and 0.86 for OKT3 (for both, P<0
8 uction, old antibody era, 1987 to 1993, when antilymphocyte globulin and muromonab-CD3 were the major
9 antithymocyte globulin (rATG; 1999) replaced antilymphocyte globulin and muromonab-CD3, with maintena
10 onsisted of induction therapy with Minnesota antilymphocyte globulin/antithymocyte globulin/OKT3 in m
11                                Antithymocyte/antilymphocyte globulins are polyclonal antihuman T-cell
12  after treatment with corticosteroids equine antilymphocyte globulin (ATGAM), or the mouse anti-human
13 es in patients who received either Minnesota antilymphocyte globulin for 5 days or more or OKT3 for 7
14 ey transplants, graft failure and the use of antilymphocyte globulin for rejection are associated wit
15                                              Antilymphocyte globulins have been used for the treatmen
16  mycophenolate mofetil, azathioprine, OKT-3, antilymphocyte globulin), only the use of antilymphocyte
17 us or cytomegalovirus status, induction with antilymphocyte globulin or antithymocyte globulin (ATG),
18 ents received 5-7 days of induction therapy (antilymphocyte globulin or antithymocyte globulin), wher
19  course of antithymocyte globulin, Minnesota antilymphocyte globulin, or OKT3 before developing PTLD.
20 d irradiation (TLI), rabbit antithymocyte or antilymphocyte globulin (RATG or RALG), and a single don
21 3, antilymphocyte globulin), only the use of antilymphocyte globulin when used to treat rejection was